DNA methylation-related chromatin modification in the regulation of mouse δ-opioid receptor gene

Guilin Wang, Tiancheng Liu, Li Na Wei, Ping Yee Law, Horace H. Loh

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


DNA methylation plays critical roles in gene-silencing through chromatin modification. We reported previously that promoter-region CpG methylation repressed mouse δ-opioid receptor (mDOR) gene expression. In the current study, we demonstrated that the methylation of mDOR gene promoter is correlated with a repressive chromatin structure that has less HaeIII and MspI nuclear accessibility and more deacetylated histone H3 and H4 than that of unmethylated mDOR promoter. Chromatin immunoprecipitation analysis showed the association of a methyl-CpG-binding domain protein 2 (MBD2) with methylated mDOR promoter. Transient expression of MBD2 enhanced the repression of partially methylated mDOR promoter activity, and this repression was partially reversed by treatment of trichostatin A, a specific histone deacetylase inhibitor, indicating that MBD2 may mediate DNA methylation-related chromatin modification through recruiting histone deacetylases to mDOR promoter region. In addition, trichostatin A treatment increased both methylated mDOR promoter activity in a transient transfection assay and endogenous mDOR mRNA level in Neuro2A cells. Taken together, these results demonstrate that the mDOR gene expression is regulated by DNA methylation-related chromatin modification, especially histone acetylation and deacetylation.

Original languageEnglish (US)
Pages (from-to)2032-2039
Number of pages8
JournalMolecular Pharmacology
Issue number6
StatePublished - Jun 2005


Dive into the research topics of 'DNA methylation-related chromatin modification in the regulation of mouse δ-opioid receptor gene'. Together they form a unique fingerprint.

Cite this